• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对他克林相关乙酰胆碱酯酶抑制剂的定量构效关系分析

QSAR analysis on tacrine-related acetylcholinesterase inhibitors.

作者信息

Wong Kai Y, Mercader Andrew G, Saavedra Laura M, Honarparvar Bahareh, Romanelli Gustavo P, Duchowicz Pablo R

机构信息

Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas INIFTA (UNLP, CCT La Plata-CONICET), Diag, 113 y 64, Sucursal 4, C,C, 16, La Plata, 1900, Argentina.

出版信息

J Biomed Sci. 2014 Sep 20;21(1):84. doi: 10.1186/s12929-014-0084-0.

DOI:10.1186/s12929-014-0084-0
PMID:25239202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4177578/
Abstract

BACKGROUND

The evaluation of the clinical effects of Tacrine has shown efficacy in delaying the deterioration of the symptoms of Alzheimer's disease, while confirming the adverse events consisting mainly in the elevated liver transaminase levels. The study of tacrine analogs presents a continuous interest, and for this reason we establish Quantitative Structure-Activity Relationships on their Acetylcholinesterase inhibitory activity.

RESULTS

Ten groups of new developed Tacrine-related inhibitors are explored, which have been experimentally measured in different biochemical conditions and AChE sources. The number of included descriptors in the structure-activity relationship is characterized by 'Rule of Thumb'. The 1502 applied molecular descriptors could provide the best linear models for the selected Alzheimer's data base and the best QSAR model is reported for the considered data sets.

CONCLUSION

The QSAR models developed in this work have a satisfactory predictive ability, and are obtained by selecting the most representative molecular descriptors of the chemical structure, represented through more than a thousand of constitutional, topological, geometrical, quantum-mechanical and electronic descriptor types.

摘要

背景

对他克林临床效果的评估表明,其在延缓阿尔茨海默病症状恶化方面具有疗效,同时证实了主要由肝转氨酶水平升高构成的不良事件。对他克林类似物的研究一直备受关注,因此我们基于其乙酰胆碱酯酶抑制活性建立定量构效关系。

结果

探索了十组新开发的与他克林相关的抑制剂,它们已在不同生化条件和乙酰胆碱酯酶来源下进行了实验测定。构效关系中纳入描述符的数量以“经验法则”为特征。所应用的1502个分子描述符可为选定的阿尔茨海默病数据库提供最佳线性模型,并针对所考虑的数据集报告了最佳定量构效关系模型。

结论

本研究中开发的定量构效关系模型具有令人满意的预测能力,是通过选择化学结构中最具代表性的分子描述符获得的,这些描述符通过一千多种组成、拓扑、几何、量子力学和电子描述符类型来表示。

相似文献

1
QSAR analysis on tacrine-related acetylcholinesterase inhibitors.对他克林相关乙酰胆碱酯酶抑制剂的定量构效关系分析
J Biomed Sci. 2014 Sep 20;21(1):84. doi: 10.1186/s12929-014-0084-0.
2
Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.他克林衍生物作为阿尔茨海默病潜在乙酰胆碱酯酶(AChE)抑制剂的联合3D-QSAR、分子对接和分子动力学研究
J Mol Model. 2015 Oct;21(10):277. doi: 10.1007/s00894-015-2797-8. Epub 2015 Oct 5.
3
Three Dimensional Quantitative Structure Activity Relationship and Pharmacophore Modeling of Tacrine Derivatives as Acetylcholinesterase Inhibitors in Alzheimer's Treatment.他克林衍生物作为阿尔茨海默病治疗中乙酰胆碱酯酶抑制剂的三维定量构效关系及药效团模型
Med Chem. 2020;16(2):155-168. doi: 10.2174/1573406415666190513100646.
4
Structure-activity relationship of tacrine and its analogues in relation to inhibitory activity against Alzheimer's disease.他克林及其类似物与抑制阿尔茨海默病活性的构效关系。
J Mol Model. 2019 Apr 11;25(5):116. doi: 10.1007/s00894-019-3993-8.
5
Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.他克林-石杉碱甲杂合物(石杉碱类):一类新型高效且具有选择性的乙酰胆碱酯酶抑制剂,有望用于治疗阿尔茨海默病。
Mini Rev Med Chem. 2001 Jul;1(2):163-74. doi: 10.2174/1389557013406972.
6
In-silico analysis and QSAR studies of tacrine hybrids with ubiquitin ligase on Alzheimer's disease.他克林与泛素连接酶的杂合物对阿尔茨海默病的计算机模拟分析和定量构效关系研究
Int J Bioinform Res Appl. 2010;6(6):556-70. doi: 10.1504/IJBRA.2010.038737.
7
Therapeutic Potential of Multifunctional Tacrine Analogues.多功能他克林类似物的治疗潜力。
Curr Neuropharmacol. 2019;17(5):472-490. doi: 10.2174/1570159X16666180412091908.
8
Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.无定向 3D-QSAR 和他克林-4-氧代-4H-色烯杂合体作为抗阿尔茨海默病药物的分子对接研究。
Comput Biol Chem. 2019 Jun;80:463-471. doi: 10.1016/j.compbiolchem.2019.05.010. Epub 2019 May 28.
9
Computational Studies on Acetylcholinesterase Inhibitors: From Biochemistry to Chemistry.乙酰胆碱酯酶抑制剂的计算研究:从生物化学到化学。
Mini Rev Med Chem. 2020;20(14):1403-1435. doi: 10.2174/1389557520666191224144346.
10
Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.新型他克林-咔唑杂合物作为治疗阿尔茨海默病潜在多功能药物的合成、生物学评价及分子模拟研究
Eur J Med Chem. 2014 Mar 21;75:21-30. doi: 10.1016/j.ejmech.2014.01.020. Epub 2014 Jan 22.

引用本文的文献

1
Application of Quantitative Structure-Activity Relationships in the Prediction of New Compounds with Anti-Leukemic Activity.定量构效关系在预测具有抗白血病活性的新化合物中的应用。
Int J Mol Sci. 2023 Jul 31;24(15):12258. doi: 10.3390/ijms241512258.
2
Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation.新型甜菊醇类 FXa 抑制剂:分子建模、计算机辅助设计与对接模拟。
Molecules. 2023 Jun 24;28(13):4977. doi: 10.3390/molecules28134977.
3
Structural, harmonic force field and vibrational studies of cholinesterase inhibitor tacrine used for treatment of Alzheimer's disease.用于治疗阿尔茨海默病的胆碱酯酶抑制剂他克林的结构、谐力场及振动研究。
Heliyon. 2023 Jun 19;9(6):e17280. doi: 10.1016/j.heliyon.2023.e17280. eCollection 2023 Jun.
4
Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer's Disease.基于计算机的阿尔茨海默病 AChE 和 BACE1 双重抑制剂的活性规则和化学片段设计开发。
Molecules. 2023 Apr 20;28(8):3588. doi: 10.3390/molecules28083588.
5
Application of Multivariate Adaptive Regression Splines (MARSplines) for Predicting Antitumor Activity of Anthrapyrazole Derivatives.多元自适应回归样条(MARSplines)在预测蒽吡唑衍生物抗肿瘤活性中的应用。
Int J Mol Sci. 2022 May 4;23(9):5132. doi: 10.3390/ijms23095132.
6
Use of connectivity index and simple topological parameters for estimating the inhibition potency of acetylcholinesterase.利用连接性指数和简单拓扑参数估算乙酰胆碱酯酶的抑制效力。
Saudi Pharm J. 2022 Apr;30(4):369-376. doi: 10.1016/j.jsps.2022.01.025. Epub 2022 Feb 8.
7
Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer's Disease.基于天然产物的计算机辅助药物设计方法在阿尔茨海默病药物研究中的应用。
Curr Neuropharmacol. 2022;20(5):857-885. doi: 10.2174/1570159X19666211005145952.
8
QSAR modeling and docking analysis of D2 receptor with known olanzapine derivatives.D2受体与已知奥氮平衍生物的定量构效关系建模及对接分析
Bioinformation. 2020 Sep 30;16(9):666-671. doi: 10.6026/97320630016666. eCollection 2020.
9
Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer's disease.用于预测乙酰胆碱酯酶和 BACE1 双重抑制剂治疗阿尔茨海默病活性的机器学习模型。
Mol Divers. 2022 Jun;26(3):1501-1517. doi: 10.1007/s11030-021-10282-8. Epub 2021 Jul 29.
10
Molecular design of antioxidant lubricating oil additives via QSPR and analysis dynamic simulation method.基于QSPR和分析动力学模拟方法的抗氧化润滑油添加剂分子设计
Heliyon. 2019 Nov 20;5(11):e02880. doi: 10.1016/j.heliyon.2019.e02880. eCollection 2019 Nov.

本文引用的文献

1
Amino acid profiles and quantitative structure-property relationship models as markers for Merlot and Torrontés wines.氨基酸谱和定量结构-性质关系模型可作为梅洛和特浓情葡萄酒的标志物。
Food Chem. 2013 Sep 1;140(1-2):210-6. doi: 10.1016/j.foodchem.2013.02.064. Epub 2013 Feb 24.
2
Quantitative structure-activity relationships of mosquito larvicidal chalcone derivatives.定量构效关系的杀蚊酮衍生物。
J Agric Food Chem. 2012 Jan 18;60(2):692-7. doi: 10.1021/jf203374r. Epub 2012 Jan 3.
3
Multi-target strategy to address Alzheimer's disease: design, synthesis and biological evaluation of new tacrine-based dimers.多靶点策略治疗阿尔茨海默病:新型他克林基二聚体的设计、合成与生物评价。
Eur J Med Chem. 2011 Sep;46(9):4336-43. doi: 10.1016/j.ejmech.2011.07.004. Epub 2011 Jul 8.
4
Advances in the replacement and enhanced replacement method in QSAR and QSPR theories.QSAR 和 QSPR 理论中替换和增强替换方法的进展。
J Chem Inf Model. 2011 Jul 25;51(7):1575-81. doi: 10.1021/ci200079b. Epub 2011 Jun 22.
5
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.胆碱能和神经保护药物治疗阿尔茨海默病和神经元血管疾病。二、高取代 2-氨基吡啶-3-氰基的新型他克林类似物的合成、生物评价和分子建模。
Bioorg Med Chem. 2011 Jan 1;19(1):122-33. doi: 10.1016/j.bmc.2010.11.040. Epub 2010 Nov 26.
6
Prediction of drug intestinal absorption by new linear and non-linear QSPR.新型线性和非线性 QSPR 预测药物肠道吸收。
Eur J Med Chem. 2011 Jan;46(1):218-28. doi: 10.1016/j.ejmech.2010.11.005. Epub 2010 Nov 9.
7
Replacement method and enhanced replacement method versus the genetic algorithm approach for the selection of molecular descriptors in QSPR/QSAR theories.替换法和增强替换法与遗传算法在 QSPR/QSAR 理论中选择分子描述符的比较。
J Chem Inf Model. 2010 Sep 27;50(9):1542-8. doi: 10.1021/ci100103r.
8
Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.抗 T. cruzi 活性及 3-芳基喹喔啉-2-甲腈二-N-氧化物的定量构效关系研究。
Bioorg Med Chem Lett. 2010 Aug 15;20(16):4831-5. doi: 10.1016/j.bmcl.2010.06.101. Epub 2010 Jun 25.
9
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates.基于他克林的双结合位点乙酰胆碱酯酶抑制剂作为有潜力的治疗阿尔茨海默病的药物候选物。
Chem Biol Interact. 2010 Sep 6;187(1-3):411-5. doi: 10.1016/j.cbi.2010.02.013. Epub 2010 Feb 16.
10
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.吡喃并[3,2-c]喹啉-6-氯他克林杂合物作为一类新型的乙酰胆碱酯酶和β-淀粉样蛋白导向的抗阿尔茨海默病化合物。
J Med Chem. 2009 Sep 10;52(17):5365-79. doi: 10.1021/jm900859q.